|A decision must be made to focus on either child data only, or to include both adult and child data. This decision should be based on clinical expertise about the condition and its trajectory at different ages. If there is likely to be physiological or developmental differences along the age span included in the review, plan a priori subgroup analyses to avoid masking these differences. |
A) Urinary tract infections present differently in children versus adults so results could be very different for adults and children.
B) Hodgkin's lymphoma has a typical age of onset of adolescence to mid-adulthood so physiological differences between children and adults are likely minimal.
|Contopoulos-Ioannidis, DG, Baltogianni MS, Ioannidis JPA, “Comparative Effectiveness of Medical Interventions in Adults Versus Children.” The Journal of Pediatrics, 157:2, 2010. Cramer K, Wiebe N, Moyer V, Hartling L, Williams K, Swingler G, Klassen TP, “Children in reviews: Methodological issues in child-relevant evidence-syntheses.” BMC Pediatrics, 5:38, 2008. |
Age-based treatment effects
|In children of 0 - 18 years, age-based treatment effects may be expected. Consider where there may be important similarities or differences in terms of physiological and psychosocial development when planning a priori subgroup analyses. |
Consider the following questions when planning age-based analyses:
1. Is there any evidence of a different/distinct form of the condition at different ages in childhood?
2. Is there any evidence that different etiological factors may be operating at different ages for that disease?
3. Is the intervention largely behavioural and therefore likely to vary according to age because of different degrees of understand and participation by the child/family unit?
|Selection of a priori outcomes based on sound knowledge of disease trajectory and children's development. Relevant short-term outcomes may differ for adults and children, or different tools may be used to assess similar outcomes. recognize that benefits and harms of treatment for children may unfold over decades of life and this may influence the outcomes assessed and study designs to be included.||Table 2 in the paper Cited presents clinical areas for which studies have been done that develop or apply methodology for selecting outcome domains or outcomes to be used in clinical trials in children younger than 16 years of age, as of 2008. || Sinha I, Jones L, Smyth RL, Williamson PR, “A Systematic Review of Studies That Aim to Determine Which Outcomes to Measure in Clinical Trials in Children.” PLoS Medicine, 5:4, 2008.|
|Which pediatric-search filters will identify material that may use varying definitions of "child" ? and may be inconsistent in indexing pediatric material. A librarian with experience using pediatric-search filters will be helpful||"Recommended precise and sensitive PubMed systematic review and child search strategies" will be of assistance.||Boluyt N, Tjosvold L, Lefebvre C, Klassen TP, Offringa M, “Usefulness of Systematic Review Search Strategies in Finding Child Health Systematic Reviews in MEDLINE.” Arch Pediatr Adolesc Med, 162:2, 2008.|